Masashi Iwamoto

1.9k citations
20 papers · 1.3k indexed · h-index 16
Topics
Hepatitis B Virus Studies (18 papers)Hepatitis C virus research (18 papers)Liver Disease Diagnosis and Treatment (5 papers)
Partner nations
JapanFranceUnited States

In The Last Decade

Masashi Iwamoto

19 papers receiving 1.3k citations

Peers

Masashi Iwamoto
Comparison fields: 5 of 70
  • Epidemiology 1.1k
  • Hepatology 818
  • Molecular Biology 244
  • Infectious Diseases 183
  • Oncology 178
Replace Senko Tsukuda with:
Senko Tsukuda Japan
Tianlun Zhou United States
Kaku Goto Japan
Christophe Ramière France
Olaf Weber Germany
Nikolaus Jilg United States
Junjun Cheng China
Dongping Xu China
Yutaka Amako United States
Han Ma United States
Masashi Iwamoto relative to Senko Tsukuda Japan Senko Tsukuda's profile →
Citations per field
00.5×
Senko Tsukuda · 1×
Citations per year

Countries citing papers authored by Masashi Iwamoto

Since Specialization
Citations

This map shows the geographic impact of Masashi Iwamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masashi Iwamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masashi Iwamoto more than expected).

Fields of papers citing papers by Masashi Iwamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masashi Iwamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masashi Iwamoto. The network helps show where Masashi Iwamoto may publish in the future.

Co-authorship network of co-authors of Masashi Iwamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Masashi Iwamoto. A scholar is included among the top collaborators of Masashi Iwamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masashi Iwamoto. Masashi Iwamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 17
3 22
4 19
5 50
6 45
7 7
8 1
9 0
10 187
11 25
12 41
13 94
14 33
15 65
16 68
17 52
18 205
19 249
20 125

About Masashi Iwamoto

Masashi Iwamoto is a scholar working on Hepatology, Virology and Epidemiology, having authored 20 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (18 papers), Hepatitis C virus research (18 papers) and Liver Disease Diagnosis and Treatment (5 papers). The work is most often cited by research in Hepatology (818 citations), Epidemiology (1.1k citations) and Virology (80 citations). Masashi Iwamoto has collaborated with scholars based in Japan, France and United States. Frequent co-authors include Koichi Watashi, Takaji Wakita, Hideki Aizaki, Ryosuke Suzuki, Senko Tsukuda, Yasuhito Tanaka, Hiroyuki Kusuhara, Masashi Mizokami, Masaya Sugiyama and Akihide Ryo. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026